1-7 of 7
Keywords: Non-small cell lung cancer
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Acta Cytologica (2019) 63 (6): 497–505.
Published Online: 03 April 2019
...Eduardo Clery; Pasquale Pisapia; Elena Vigliar; Umberto Malapelle; Claudio Bellevicine; Giancarlo Troncone; Fernando C. Schmitt In the late stages of non-small cell lung cancer, the detection of sensitizing mutations of the epidermal growth factor receptor ( EGFR ) is mandatory to select patients...
Journal Articles
Acta Cytologica (2019) 63 (6): 489–496.
Published Online: 19 December 2018
...Pasquale Pisapia; Umberto Malapelle; Giancarlo Troncone The identification of non-small cell lung cancer (NSCLC) patients potentially responsive to targeted therapies relies on a number of relevant biomarkers, including EGFR , ALK , ROS-1, and PD-L1. Biomarker identification is most commonly based...
Journal Articles
Journal Articles
Acta Cytologica (2012) 56 (6): 590–595.
Published Online: 01 December 2012
... Non-small cell lung cancer Core biopsy Lung cancer is the number one cause of cancer-related death in men and women in the USA [ 1,2,3 ]. Traditionally, lung carcinomas have been broadly divided into small cell carcinoma (SCC) and non-small cell lung carcinoma (NSCLC). NSCLC, which comprises...
Journal Articles
Acta Cytologica (2012) 56 (6): 661–668.
Published Online: 01 December 2012
...Edmond S.K. Ma; Wai-Kuen Ng; Chris L.P. Wong Activating mutations of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer predicts a significantly higher clinical response rate to tyrosine kinase inhibitors targeting EGFR, and it is currently recommended that patients...
Journal Articles
Acta Cytologica (2012) 56 (4): 419–424.
Published Online: 25 July 2012
...Hillary Z. Kimbrell; Karen S. Gustafson; Min Huang; Hormoz Ehya Objectives: To determine the diagnostic accuracy of cytomorphology for subclassifying non-small cell lung cancer into adenocarcinoma (AC) and squamous cell carcinoma (SqC), and the utility of immunocytochemistry (ICC) for poorly...